Anti-Osteoporosis Fracture Healing Market to Reach USD 23,558.5 Million by 2035 at a 4.2% of CAGR, Driven by Aging Population & Innovation

February 17, 2025 2:30 AM

The global Anti-Osteoporosis Fracture Healing Market is poised for significant growth over the next decade. Valued at USD 15,612.4 million in 2025, the market is projected to reach USD 23,558.5 million by 2035, reflecting a compound annual growth rate (CAGR) of 4.2%.The market for osteoporosis treatment is expected to experience growth due to the increasing prevalence of the disease and an increase in the number of affected patients. Key players...

Read more

Interim report January - December 2024: Our Rapid Growth Journey Continued in 2024 with a 65% Growth Rate

February 17, 2025 2:00 AM

Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB's (publ) interim report for January - December 2024 is now available on the company's website www.senzime.com.Financial information October - December 2024• Net sales amounted to TSEK 14,034 (10,850), an increase of 29 percent.• Currency-adjusted net sales increased by 28 percent.• Sales of disposable sensors amounted to TSEK 11,042 (6,647), an increase of 66 percent.• In the USA, net sales increased to...

Read more

Infinx Healthcare to Debut Revenue Cycle Agent Platform and Document Capture AI Agent Platform at ViVE 2025

February 16, 2025 9:00 AM

Infinx Healthcare, a leader in AI-powered revenue cycle management solutions, will debut its Revenue Cycle Agent Platform and Document Capture AI Platform at ViVE 2025 in Nashville, Tennessee. These agentic platforms integrate Generative AI (GenAI), automation, and human expertise to improve financial outcomes and eliminate inefficiencies in revenue cycle workflows.As RCM complexity increases, AI and automation alone are not enough to deliver...

Read more

The Science of Movement: How Physiowell Utilizes Advanced Techniques for Optimal Recovery

February 14, 2025 8:30 PM

Physiotherapy has evolved, embracing new physiotherapy technology and recovery processes. Physiowell offers customized recovery plans. In this blog, we talk about the innovative processes that make our UAE physio center perfect for patient outcomes.The Role of Technology in PhysiotherapyThe main advantages of advanced technology in physiotherapy are:Increased Accuracy: Robotic rehabilitation physiotherapy can deliver accurate movements and...

Read more

Encision Reports Third Quarter Fiscal Year 2025 Results

February 14, 2025 7:30 PM

Encision Inc. (OTC PINK:ECIA), a medical device company that owns the patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today announced financial results for its fiscal 2025 third quarter that ended December 31, 2024. The Company posted quarterly product net revenue of $1.46 million and service net revenue of $128 thousand, or total net revenue of $1.59 million...

Read more

Onco-Innovations' Nanoparticle Formulation PNKP Technology Combined with Radiation Therapy, and as a Standalone Treatment, Shown in Studies to Slow Colorectal Cancer Tumour Growth

February 14, 2025 6:00 PM

Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to provide information on its licensed nanoparticle formulation of a new class of Polynucleotide Kinase 3'-Phosphatase (PNKP) inhibitors (the "Technology" or "PNKP Compound"), which has shown effectiveness in slowing the growth of colorectal cancer (CRC) tumours when used as a standalone treatment and in combination with radiation therapy, based...

Read more

ViVE 2025 AI Power Rankings: Essential Vendors Delivering Tangible Healthcare Outcomes

February 14, 2025 3:00 PM

As healthcare organizations increasingly seek to leverage artificial intelligence (AI) for enhanced efficiency, diagnostics, and patient engagement, ViVE 2025 stands as a critical platform to distinguish genuine innovation from mere market buzz. Amidst the allure of vendor sponsorships, sponsored speakers, panels, and glitzy trade show booths, healthcare executives, IT leaders, and decision-makers must prioritize AI vendors offering tangible,...

Read more

DirectTrust(R) Announces Accreditation Criteria for New Identity Provider and UDAP Identity Provider Programs Available for Public Review

February 14, 2025 9:30 AM

DirectTrust®, a non-profit healthcare industry alliance focused on furthering trust in healthcare technology and data exchange through standards, accreditation, and other services, today announced a 60-day public comment and review period of the draft criteria of its new DirectTrust Identity Provider (IdP) Accreditation Program and the optional UDAP™ Identity Provider Program.The DirectTrust IdP Accreditation Program ensures identity providers...

Read more

Nucs AI Wins Cannes Neuron Award for Healthcare Innovation and Paves the Way for the Future of AI-Driven Radiology

February 14, 2025 9:00 AM

Nucs AI, a leader in AI-driven radiology solutions, is proud to announce that it has been awarded the prestigious Cannes Neuron Award in the Healthcare category. This marks the first time the Healthcare category has been included in the Cannes Neuron Awards, making Nucs AI the inaugural winner. This recognition underscores Nucs AI's pioneering advancements in artificial intelligence for medical imaging, transforming diagnostics and workflow...

Read more

Aptevo Therapeutics Reports 2024 Financial Results And Provides A Business Update

February 14, 2025 8:05 AM

SEATTLE, WA / ACCESS Newswire / February 14, 2025 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR® and ADAPTIR-FLEX® platform technologies, today reported financial results for the year ended December 31, 2024 and provided a business update.Business Update"2024 was a successful year for Aptevo, as we've demonstrated the...

Read more

Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference

February 14, 2025 8:00 AM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that it will participate in the 2025 J.P. Morgan Global Leveraged Finance Conference in Miami Beach, Florida on February 24. A live audio webcast of the event will be accessible on the Investor Relations section of Bausch Health's website.DetailsDate: Monday, February 24, 2025Time: 8:45 a.m. U.S. ESTWebcast: http://ir.bauschhealth.com/events-and-presentationsA replay of the event...

Read more

Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates

February 14, 2025 6:28 AM

CAMBRIDGE, MA / ACCESS Newswire / February 14, 2025 / Moderna, Inc. (NASDAQ:MRNA) today reported financial results and provided business updates for the fourth quarter and fiscal year 2024."We have made progress in 2024 across our late-stage pipeline and cost reduction efforts. Our team successfully filed three Biologics License Applications in the final months of the year and reduced our costs by 27 percent compared to 2023," said Stéphane...

Read more

Rubicon Recovery Center Announces Expansion into Comprehensive Mental Health Services

February 14, 2025 4:00 AM

Rubicon Recovery Center, a leading addiction rehabilitation facility in Watchung, New Jersey, is proud to announce the upcoming launch of its comprehensive mental health program, Rubicon Mental Health. This initiative reflects the center's commitment to addressing the growing demand for advanced mental health treatments by integrating traditional psychotherapy and medication management with a wide array of holistic and neuroscience-based...

Read more

Global Birth Tissue Products Market to Reach USD 5,123.1 Million by 2035, Surging at 6.6% CAGR from 2025 to 2035, Driven by Regenerative Medicine and Biotech Innovations | FMI Research

February 14, 2025 3:30 AM

According to a Future Market Insights (FMI), the global birth tissue products market is projected to witness significant growth in the coming decade, fueled by rising awareness, increasing adoption, and advancements in regenerative medicine. The market, valued at USD 2,695.9 Million in 2025, is expected to reach USD 5,123.1 Million by 2035, growing at a CAGR of 6.6% during the forecast period.Birth tissue products are derived from donated human...

Read more

iZafe Group Q4 Interim Report, October-December 2024 and New Forecast

February 14, 2025 3:00 AM

iZafe Group (STO:IZAFE-B.ST) iZafe Group AB (publ.) presents today, February 14, its report for the fourth quarter.Financial Performance in SummaryTotal revenue for the quarter amounted to 2,751 (1,052) TSEK, more than doubling compared to the same period last year. The increase is primarily driven by hardware sales to the Netherlands, which is expected to generate recurring revenue in 2025 as the market establishes itself and implementation...

Read more

Pharmacists Group Unveils IRA Effectuation Plan Recommendations

February 13, 2025 5:00 PM

Today, ASCP released recommendations for pharmaceutical manufacturers on how best to craft their maximum fair price (MFP) effectuation plans related to prices negotiated under the Inflation Reduction Act (IRA.) The recommendations range from dispute resolution and cashflow mitigation to audits, 340B deduplication and utilization of the Medicare Transition Facilitator."As manufacturers work to craft their IRA effectuation plans, we understand the...

Read more

Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress

February 13, 2025 4:03 PM

Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today reported financial results for its first quarter of fiscal 2025 ended December 31, 2024. The Company's Form 10-Q, once filed, can be viewed on the SEC Filings page of its Investor Relations website.Recent Corporate and Operational Updates:Corporate:In December 2024, the Company announced a strategic restructuring of its...

Read more

Integrated BioPharma Reports Results for its Quarter Ended December 31, 2024

February 13, 2025 3:55 PM

Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2024.Revenue for the quarter ended December 31, 2024 was $12.6 million compared to $11.5 million for the quarter ended December 31, 2023, an increase of $1.1 million or 9.6%. The Company had operating income in the quarter ended December 31, 2024 of approximately $0.2 million compared to an operating loss in the...

Read more

My Quest Story - Manny Cetina

February 13, 2025 3:30 PM

I started as a Route Service Representative back in March 1984 at a small lab in Cambridge, Massachusetts called Spectrum Medical Labs as one of only six drivers. Spectrum was acquired by Met Path and Corning and eventually became Quest Diagnostics. Before I started as an RSR, I was a single 21-year-old construction worker in Chelsea, Massachusetts who never thought about ever working in the medical field. But one day, my brother-in-law talked...

Read more

CORRECTING AND REPLACING: Theralase(R) Demonstrates Effective Treatment of Herpes

February 13, 2025 12:30 PM

Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light, radiation, sound and/or drug-activated small molecules and their formulations, intended for the safe and effective destruction of various cancers, bacteria and viruses, is pleased to announce that the previous University of Manitoba research has now been validated,...

Read more